Advertisement

Banner Biovision 2014 Lyon France April 600x60px
Document › Details

Clavis Pharma ASA. (1/18/12). "Press Release: Clavis Pharma. Raises NOK 163 Million in Private Placement". Oslo.

Organisations Organisation Clavis Pharma ASA
  Today Aqualis ASA
  Group Aqualis ASA
  Organisation 2 Braganza AS
Products Product elacytarabine
  Product 2 CP-4126 (CO-101)
Index term Index term Clavis Pharma–SEVERAL: investment, 201201 private placement NOK163m 2.86m new shares NOK53/share
Persons Person Hellebø, Olav (Clavis Pharma 201108 CEO)
  Person 2 Manum, Gunnar (Clavis Pharma 201107 CFO)
     


   
Record changed: 2013-06-09

Advertisement

Banner BIO Deutschland Deutsche Biotechnologietage 2015 Köln 600x60px

More documents for Aqualis ASA


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Banner Biovision 2014 Lyon France April 600x60px




» top

Advertisements

Banner EBD Group BIO-Europe Spring 2015 BES Paris France March 120x240px Banner BIO Deutschland Deutsche Biotechnologietage 2015 Köln 120x240px Banner C5 Communications Biotech Patent Litigation 2015 Amsterdam 120x180px Banner Biovision 2014 Lyon France April 120x180px Banner Nanjing Pushlong Exhibition 2015 Biotech China September 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px